Michelle Seitz, head of William Blair Investment Management, has been named a “top woman in asset management” by Money Management Executive. All of the women selected in this year's Money Management Executive's Top Women in Asset Management Awards are bona fide leaders and innovators, actively seeking solutions to the market, regulatory and operational challenges facing firms,” writes Money Management Executive.
William Blair initiated research coverage of Fusion Pharmaceuticals Inc. (FUSN $2.53) and POINT Biopharma Global Inc. (PNT $6.81), two companies in what analyst Andy Hsieh describes as the “reignited” space of radiopharmaceuticals for the treatment of cancer.Read more
The five appointments build upon the recent growth of the firm’s investment banking group.Read more
In this Economics Weekly, we discuss the longer-term outlook for inflation and whether or not we really are entering a longer-term period of sustained higher inflation.Read more
Are you sure you want to leave?
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures